BrainsWay's Growth Flywheel: A Platform for Interventional Psychiatry Takes Shape BrainsWay (BWAY) has achieved significant momentum in its evolution into a broader platform for interventional psychiatry.
The company's Q2 2026 earnings demonstrate accelerating growth, expanding profitability, and increasing visibility into future revenue. The quarterly results are impressive: $17.
1 million in revenue, representing a 35% increase; operating income up over 300%; and an adjusted EBITDA margin of 20%.